Macular Disease Foundation Australia (MDFA) is inviting applications for funding to support ground-breaking research into macular disease.
The Foundation – Australia’s largest nongovernment source of funding for world-leading research that aims to reduce the incidence and impact of macular disease – has committed AU$5.1 million across 29 projects since the research grants program was launched in 2011.
Notable past recipients of MDFA funding include Professor Paul Mitchell AO, Professor Robyn Guymer, Professor Mark Gillies, and Associate Professor Fred Chen, to name a few.
RIGOROUS EVALUATION
Peer review and rigorous evaluation based on the National Health and Medical Research Council (NHMRC) process has always ensured the successful applicants meet high standards. New to the 2023 evaluation process will be the inclusion of a community review panel, reflecting MDFA’s desire to represent the voice of the macular disease community.
“We see this as a welcome addition to a very successful program,” said Dr Kathy Chapman, MDFA’s CEO. “Our research program exists because our community is deeply committed to advancing understanding of this disease. We hope that the Community Review Panel will contribute to the funding decisions through their lived experience, making the research we fund even more relevant to the needs of the community, as well as being scientifically rigorous.”
BLUE SKY RESEARCH OPPORTUNITY
Once again, the Grant Family Fund – a legacy gift in honour of the late Faye Grant and her father Ronald Grant – will offer a total pool of up to $100,000 for early-career researchers for ‘blue-sky’ research in the field of macular disease.
The Grant Family Fund invests in creative and innovative projects by early-career Australian researchers that show potential for future funding by granting bodies, in accordance with the principles of the NHMRC.
APPLY NOW
Applications close at 5pm (AEDT) on 31 January 2023 and the successful applicants will be announced in May 2023. For more information visit: www.mdfoundation.com.au
